首页> 外文期刊>Acta clinica Croatica >FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER
【24h】

FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER

机译:早期乳腺癌的年轻女性的生育保存

获取原文
获取原文并翻译 | 示例
       

摘要

Although breast cancer (BC) occurs more often in older women, it is the most commonly diagnosed malignancy in women of childbearing age. Owing to the overall advancement of modern medicine and the growing global trend of delaying childbirth until later age, we find ever more younger women diagnosed and treated for BC who have not yet completed their family. Therefore, fertility preservation has emerged as a very important quality of life issue for young BC survivors. This paper reviews currently available options for fertility preservation in young women with early-stage BC and highlights the importance of a multidisciplinary approach to fertility preservation as a very important quality of life issue for young BC survivors. Pregnancy after BC treatment is considered not to be associated with an increased risk of BC recurrence; therefore, it should not be discouraged for those women who want to achieve pregnancy after oncologic treatment. Currently, it is recommended to delay pregnancy for at least 2 years after BC diagnosis, when the risk of recurrence is highest. However, BC patients of reproductive age should be informed about the potential negative effects of oncologic therapy on fertility, as well as on the fertility preservation options available, and if interested in fertility preservation, they should be promptly referred to a reproductive specialist. Early referral to a reproductive specialist is an important factor that increases the likelihood of successful fertility preservation. Embryo and mature oocyte cryopreservation are currently the only established fertility preservation methods but they require ovarian stimulation (OS), which delays initiation of chemotherapy for at least 2 weeks. Controlled OS does not seem to increase the risk of BC recurrence. Other fertility preservation methods (ovarian tissue cryopreservation, cryopreservation of immature oocytes and ovarian suppression with gonadotropin-releasing hormone agonists) do not require OS but are still considered to be experimental techniques for fertility preservation.
机译:虽然乳腺癌(BC)常常发生在老年女性中,但它是育龄妇女最常见的恶性肿瘤。由于现代医学的总体进展以及延迟分娩的延迟延迟进入的全球趋势,我们发现尚未完成其家庭的BC诊断和治疗的更年轻的女性。因此,生育保存已成为年轻的BC幸存者的一个非常重要的生活质量问题。本文评估了具有早期公元前阶段的年轻妇女的生育保存的现行选择,并强调了多学科方法对生育保存的重要性,作为年轻的BC幸存者的一个非常重要的生活质量问题。 BC治疗后怀孕被认为不与BC复发的风险增加有关;因此,对于那些想要在肿瘤治疗后患者妊娠的女性不应该劝阻。目前,在BC诊断后至少2年后建议延迟怀孕,当复发的风险最高时。然而,BC患者的生殖年龄患者应了解肿瘤治疗对生育的潜在负面影响,以及可用的生育保存选择,如果对生育保存有兴趣,他们应该迅速提及生殖专家。早期转诊到生殖专家是增加成功生育保存的可能性的重要因素。胚胎和成熟的卵母细胞冷冻保存是目前唯一建立的生育保存方法,但它们需要卵巢刺激(OS),其延迟化疗的开始至少2周。受控操作系统似乎没有增加BC复发的风险。其他生育保存方法(卵巢组织冷冻保存,不成熟的卵母细胞和卵巢抑制与促性腺激素释放激素激动剂的冷冻保存)不需要OS,但仍被认为是生育保存的实验技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号